The human JC polyomavirus (JCV) causes a fatal demyelinating disease, progressive multifocal leukoencephalopathy (PML), in immunocompromised individuals. Current treatment options for PML are inadequate. Sialylated oligosaccharides and the serotonin receptor are known to be necessary for JCV entry, but the molecular interactions underlying JCV attachment remain unknown. Using glycan array screening and viral infectivity assays, we identify a linear sialylated pentasaccharide with the sequence NeuNAc-α2,6-Gal-β1,4-GlcNAc-β1,3-Gal-β1,4-Glc (LSTc) present on host glycoproteins and glycolipids as a specific JCV recognition motif. The crystal structure of the JCV capsid protein VP1 was solved alone and in complex with LSTc. It reveals extensive interactions with the terminal sialic acid of the LSTc motif and specific recognition of an extended conformation of LSTc. Mutations in the JCV oligosaccharide-binding sites abolish cell attachment, viral spread, and infectivity, further validating the importance of this interaction. Our findings provide a powerful platform for the development of antiviral compounds.
The n class="Species">humanpan> class="Species">JC polyomavirus (JCV) causes a fatal demyelinating disease, progressive multifocal leukoencephalopathy (PML), in immunocompromised individuals. Current treatment options for PML are inadequate. Sialylated oligosaccharides and the serotonin receptor are known to be necessary for JCV entry, but the molecular interactions underlying JCV attachment remain unknown. Using glycan array screening and viral infectivity assays, we identify a linear sialylated pentasaccharide with the sequence NeuNAc-α2,6-Gal-β1,4-GlcNAc-β1,3-Gal-β1,4-Glc (LSTc) present on host glycoproteins and glycolipids as a specific JCV recognition motif. The crystal structure of the JCV capsid protein VP1 was solved alone and in complex with LSTc. It reveals extensive interactions with the terminal sialic acid of the LSTc motif and specific recognition of an extended conformation of LSTc. Mutations in the JCVoligosaccharide-binding sites abolish cell attachment, viral spread, and infectivity, further validating the importance of this interaction. Our findings provide a powerful platform for the development of antiviral compounds.
Authors: Gert Van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Séverine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts Journal: N Engl J Med Date: 2005-06-09 Impact factor: 91.245
Authors: Helge Ewers; Winfried Römer; Alicia E Smith; Kirsten Bacia; Serge Dmitrieff; Wengang Chai; Roberta Mancini; Jürgen Kartenbeck; Valérie Chambon; Ludwig Berland; Ariella Oppenheim; Günter Schwarzmann; Ten Feizi; Petra Schwille; Pierre Sens; Ari Helenius; Ludger Johannes Journal: Nat Cell Biol Date: 2009-12-20 Impact factor: 28.824
Authors: Kenneth R Carson; Daniele Focosi; Eugene O Major; Mario Petrini; Elizabeth A Richey; Dennis P West; Charles L Bennett Journal: Lancet Oncol Date: 2009-08 Impact factor: 41.316
Authors: Hans Lindå; Anders von Heijne; Eugene O Major; Caroline Ryschkewitsch; Johan Berg; Tomas Olsson; Claes Martin Journal: N Engl J Med Date: 2009-09-10 Impact factor: 91.245
Authors: Angelina S Palma; Ten Feizi; Yibing Zhang; Mark S Stoll; Alexander M Lawson; Esther Díaz-Rodríguez; María Asunción Campanero-Rhodes; Júlia Costa; Siamon Gordon; Gordon D Brown; Wengang Chai Journal: J Biol Chem Date: 2005-12-21 Impact factor: 5.157
Authors: Ivan Jelcic; Benoit Combaluzier; Ilijas Jelcic; Wolfgang Faigle; Luzia Senn; Brenda J Reinhart; Luisa Ströh; Roger M Nitsch; Thilo Stehle; Mireia Sospedra; Jan Grimm; Roland Martin Journal: Sci Transl Med Date: 2015-09-23 Impact factor: 17.956
Authors: Miriam Becker; Melissa Dominguez; Lilo Greune; Laura Soria-Martinez; Moritz M Pfleiderer; Rachel Schowalter; Christopher B Buck; Bärbel S Blaum; M Alexander Schmidt; Mario Schelhaas Journal: J Virol Date: 2019-03-05 Impact factor: 5.103
Authors: Colleen L Mayberry; Ashley N Soucy; Conner R Lajoie; Jeanne K DuShane; Melissa S Maginnis Journal: J Virol Date: 2019-04-03 Impact factor: 5.103
Authors: Bethany A O'Hara; Chamila Rupasinghe; Achani Yatawara; Gabriel Gaidos; Dale F Mierke; Walter J Atwood Journal: Virus Res Date: 2014-06-21 Impact factor: 3.303